Novartis Ag (NVSEF) FCF Margin (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) FCF Margin (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -1,862.00
Mar 31, 2023 -219,618.00
Dec 31, 2022 215,439.00
Sep 30, 2022 6,225.00
Jun 30, 2022 -6,861.00
Mar 31, 2022 7,350.00
Dec 31, 2021 -12,881.00
Sep 30, 2021 12,094.00
Jun 30, 2021 -5,317.00
Mar 31, 2021 -280,915.00
Dec 31, 2020 277,947.00
Sep 30, 2020 8,022.00
Jun 30, 2020 -6,216.00
Jun 30, 2019 -11,763.00
Mar 31, 2019 -7,474.00
Dec 31, 2018 7,905.00
Sep 30, 2018 8,377.00
Jun 30, 2018 -8,979.00
Mar 31, 2018 -19,414.00
Dec 31, 2017 11,688.00